Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Abramowicz

Showing results (111-120 of 156) with videos related to

Pageof 16
Sort By:
Revue Medicale De Bruxelles|February 15, 2003
[The medico-surgical department of nephrology dialysis and renal transplantation]J L Vanherweghem, D Abramowicz, N Broeders, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1995
Inability of OKT3 to prevent donor-derived ABO hemolytic anemia in a kidney-pancreas transplant recipientJ M Doutrelepont, D Abramowicz, M Lambermont, et al.
The Journal of Experimental Medicine|February 1, 1993
In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin AP Durez, D Abramowicz, C Gérard, et al.
Kidney International|November 1, 1992
Procoagulant effect of the OKT3 monoclonal antibody: involvement of tumor necrosis factorO Pradier, A Marchant, D Abramowicz, et al.
Lancet (London, England)|March 28, 1992
Induction of thromboses within renal grafts by high-dose prophylactic OKT3D Abramowicz, O Pradier, A Marchant, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 1, 1994
OKT3 serum levels as a guide for prophylactic therapy: a pilot study in kidney transplant recipientsD Abramowicz, M Goldman, O Mat, et al.
Transplantation|May 27, 1994
Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10V Donckier, V Flament, C Gérard, et al.
Transplantation Proceedings|April 1, 1993
Prophylactic OKT3: practical considerations for the prevention of first-dose reactionsJ M Doutrelepont, D Abramowicz, B Borre, et al.
The Journal of Experimental Medicine|January 1, 1992
The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytesD De Wit, M Van Mechelen, M Ryelandt, et al.
Therapeutic Drug Monitoring|September 26, 2003
Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetilD R J Kuypers, Y Vanrenterghem, J P Squifflet, et al.
Pageof 16

Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Revue Medicale De Bruxelles|February 15, 2003
[The medico-surgical department of nephrology dialysis and renal transplantation]J L Vanherweghem, D Abramowicz, N Broeders, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1995
Inability of OKT3 to prevent donor-derived ABO hemolytic anemia in a kidney-pancreas transplant recipientJ M Doutrelepont, D Abramowicz, M Lambermont, et al.
The Journal of Experimental Medicine|February 1, 1993
In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin AP Durez, D Abramowicz, C Gérard, et al.
Kidney International|November 1, 1992
Procoagulant effect of the OKT3 monoclonal antibody: involvement of tumor necrosis factorO Pradier, A Marchant, D Abramowicz, et al.
Lancet (London, England)|March 28, 1992
Induction of thromboses within renal grafts by high-dose prophylactic OKT3D Abramowicz, O Pradier, A Marchant, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 1, 1994
OKT3 serum levels as a guide for prophylactic therapy: a pilot study in kidney transplant recipientsD Abramowicz, M Goldman, O Mat, et al.
Transplantation|May 27, 1994
Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10V Donckier, V Flament, C Gérard, et al.
Transplantation Proceedings|April 1, 1993
Prophylactic OKT3: practical considerations for the prevention of first-dose reactionsJ M Doutrelepont, D Abramowicz, B Borre, et al.
The Journal of Experimental Medicine|January 1, 1992
The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytesD De Wit, M Van Mechelen, M Ryelandt, et al.
Therapeutic Drug Monitoring|September 26, 2003
Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetilD R J Kuypers, Y Vanrenterghem, J P Squifflet, et al.
Pageof 16